Siemens Healthcare Diagnostics, Inc. has recalled the Atellica CH Revised C Reactive Protein (RCRP) assay due to a software issue that may cause incorrect flagging. This defect could potentially lead to erroneous test results being reported to healthcare providers for patients. This laboratory assay is used in hospitals and medical facilities, and while no injuries or incidents have been reported, the error could impact clinical decisions.
The software failure may lead to incorrect test results, which could cause a healthcare provider to provide an inaccurate diagnosis or inappropriate medical treatment.
Recall Number: Z-1551-2025
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.